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Plus maze testStudies showing anxiolytic-like properties of natural products have grown. This paper evaluated if carvacryl ac-
etate (CA) could be studied as an alternative drug to treat anxiety disorders. Elevated plus maze (EPM) tests ,
light-dark box (LDB) tests, and marble-burying tests (MBTs) were performed on mice. In the ﬁrst protocol, the
anxiolytic-like activities of CA 25, 50, 75 and 100 mg/kg at single doses were compared to those of the vehicle,
buspirone 5 mg/kg (BUSP) and diazepam 1 mg/kg (DZP). In the second protocol, the anxiolytic-like actions of
CAwere tested for GABAergic and serotonergic systems. The time spent in the open arms (TSOA) and the number
of open arms entries (NOAE) were measured in EPM; the time spent in the light box (TSLB) and the number of
entries to light box (NELB) were measured in LDB; and the number of marbles buried (NMB) were measured in
MBT. CA increased TSOA andNOAE in the EPM, aswell as TSLB and NELB in the LDB and the NMB in theMBT. The
anxiolytic-like activity of CA 25; 50; 75 and 100 mg/kg was not associated with psychomotor retardation in the
open ﬁeld test and in the Rota rod test, contrarily withwhat happenedwith DZP. In the second protocol, to suggest
the mechanism of action of CA, ﬂumazenil 25 mg/kg ip (FLU) and WAY 100,635 10 mg/kg ip (WAY–5-HT1A
antagonist) were also used. FLU + CA100 reduced TSOA in the EPM when compared to CA100 but
WAY + CA100 did not. In LDB, FLU + CA100 reduced the TSLB when compared to CA100 but WAY + CA100
did not. In theMBT, FLU + CA100 inhibited the effect of CA100 on the NMB butWAY + CA100 did not. In conclu-
sion, CA seems to have an anxiolytic-like effect, probably due to GABAergic agonist action, without psychomotor
side effects.
© 2013 Published by Elsevier Inc.1. Introduction
Anxiety is a behavioral mechanism in animals to cope with difﬁcult
situations. Fear and anxiety share the same physical and mental symp-
toms, like avoidance, hypervigilance and an increased alert level to
avoid damage (Bernick, 2010; Higgins and George, 2010).e; CA, carvacryl acetate; DZP,
onene; FLU, ﬂumazenil; GABA,
arble-burying test; NF, number
mber of marbles buried; NOAE,
ssed; OFT, open-ﬁeld test; SSRI,
spent in light box; TSOA, time
ar; WAY, WAY 100635.
m Neuroquímica Experimental,
rio Ministro Petrônio Portella,
4.049-550, Brazil. Tel.: +55 86
ivelilson@pq.cnpq.br
vier Inc.Anxiety disorders, which are among the most prevalent psychiatric
conditions in most populations, produce morbidity, frequent use of
health services, impair the functional performance of the individual
and comorbidities with chronic medical conditions (Campbell-Sills
et al., 2013; Johansson et al., 2013).
However, most patients with anxiety disorders experience a pro-
gressive reduction of their symptoms with continuous use of selective
serotonin reuptake inhibitors (SSRIs) and immediate symptom relief
with benzodiazepines (BDZ), as diazepam (DZP) (Ravindran and Stein,
2010). Buspirone (BUSP) is another drug used to treat anxiety symptoms
(Celada et al., 2013). These drugs which reduce anxiety are described as
anxiolytic drugs and act by altering the chemical synaptic transmission
in the brain.
Several studies have shown that certain substances derived from
plants may have central nervous system (CNS) effects, such as the
ethanolic extract from Platonia insignis (Costa Júnior et al., 2010), the
Citrus limon essential oil (Campêlo et al., 2011), the Bellis perennis
(Marques et al., 2011), the essential oil from Eupatorium triplinerve
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1,4 cineole (Gomes et al., 2010), linalool (Souto-Maior et al., 2011),
carvone (Costa et al., 2012) and epoxy-limonene (Almeida et al., 2012).
Accordingly, this study evaluated if carvacryl acetate (CA) has poten-
tial to be studied as an alternative drug to treat anxiety disorders. CA
(Fig. 1), a semisynthetic monoterpenic ester, is derived from carvacrol,
a component of oregano (Origanum vulgare L.) oil (Manou et al., 1998).
Carvacrol has also been recognized to have anxiolytic-like potential in
animal models of anxiety (Melo et al., 2010).
The elevated plus-maze (EPM) test, the light-dark box (LDB) test
and the marble-burying test (MBT) were applied in mice treated with
a single dose of CA to identify its anxiolytic-like potential (Badgujar
and Surana, 2010; Deacon, 2013).
Flumazenil (FLU), a GABAergic antagonist, and N-{2-[4-(2-metho
xyphenyl)-1-piperazinyl] ethyl}-N-(2-pyridyl) cyclohexanecarboxamide
–WAY 100635 (WAY), a selective antagonist of 5-HT1A receptor – were
applied previously to CA to suggest its mechanism of action (Dalvi and
Rodgers, 1999; Castro et al., 2008).
An open-ﬁeld test (OFT) and a Rota-rod test were used to evaluate if
the probable action of CA on the CNS is related to sedative andmuscular
relaxation effects. The effect of a single dose of CA on the CNS was com-
pared with single doses of DZP and BUSP, which are standard drugs to
treat anxiety disorders (Celada et al., 2013; Ravindran and Stein, 2010).
2. Material and methods
2.1. Reagents and drugs
Polyoxyethylene sorbitan monooleate (Tween 80) (Eg Sigma Chem.
Co., St. Louis, Missouri, USA) was used as the vehicle in the groups.
DZP andBUSP (Union Chemical, Brazil) were used as standard anxiolytic
drugs. FLU and WAY were obtained from Eg Sigma Chem. Co., St. Louis,
Missouri, USA. All the administrations were in acute form – single
doses – intraperitoneally (ip).
2.2. Substance preparation
DZP, BUSP, WAY and FLU were emulsiﬁed with 0.2% Tween 80 and
dissolved in distilled water. DZP was administered at a dose of 1 mg/kg,
which is considered an anxiolytic dose on rodents (Bert et al., 2001).
BUSP was used at 5 mg/kg, which is considered an anxiolytic dose on
rodents (López-Rubalcava et al., 1999). FLU was used at 25 mg/kg and
WAY at 10 mg/kg. Negative controls received only 0.2% of Tween 80
dissolved in distilled water (10 ml/kg).
CAwas obtained by the carvacrol acetylation procedure, which used
the acylating agent acetic anhydride as catalyst. There were carvacrol
(5 g, 0.033 mol), pyridine (7.5 ml) and acetic anhydride (12.5 ml) in
a ﬂask (50 ml) equipped with magnetic stirrer, coupled to a Friedrich
condenser and with an inert atmosphere. Then the solution was
subjected to a constant magnetic stirring and reﬂux for about 24 h.OO
Fig. 1. Chemical structure of carvacryl acetate (5-isopropyl-2-methyl-phenyl).The reactionmixture was poured into icewater (60 ml), and the ex-
traction of the reaction product was done into a decantation funnel,
using chloroform as a solvent extractor (3 × 60 ml). Chloroform phases
were combined and washed with saturated copper sulfate (3 × 60 ml).
The chloroform phases were also washed with water (3 × 60 ml) and
driedwith anhydrousNa2SO4. Subsequently, the solventwas evaporated
on a rotary evaporator. The reaction product was subjected to column
chromatography, using silica gel as the stationary phase and a mixture
of hexane, CA (95:5), as the mobile phase.
With a 76% yield, approximately, 4779 g (0.025 mol) of CA was
obtained, chemically deﬁned as 5-isopropyl-2-methyl-phenyl (Fig. 1),
having a purity of 98%, molecular weight of 192.26 g/mol, refractive
index of 1497, boiling point of 94.56 °C at 760 mm Hg, enthalpy of
vaporization of 48,414 kJ/mol and density 0.994 g/cm3 (Vogel et al.,
1996). Its color is yellow-green. It has an astringent and pungent taste
and the characteristic odor of oregano (Origanum vulgare L.). CA is
found in a liquid state at room temperature, with a density of 0.994 ±
0.06 g/cm3.
The conﬁrmation of the chemical structure of CA was performed
by infrared (IR) spectroscopic data, 1H NMR and 13C NMR DEPT: IR
(4000–400 cm−1): 3050; 2950; 2850; 1750; 1500; 850. 1H NMR
(200 MHz, CDCl3): 7.20 (d, J = 7,80 Hz, 1H); 7,00 (d, J = 7,80 Hz,
1H); 6,90 (s, 1H); 2,95–2,75 (m, 1H); 2,30 (s, 3H); 2,15 (s, 3H); 1,26
(d, J = 6,80 Hz, 6H); 13C NMR DEPT (50 MHz, CDCl3): 169,1; 149,1;
147,9; 130,7; 127,0; 124,0; 119,6; 67,3; 33,4; 23,7; 20,6; 15.6.
Subsequently, CAwas emulsiﬁedwith 0.05% Tween 80 (Sigma Chem.
Co., St. Louis, Missouri, USA) dissolved in distilled water (vehicle) and
administered intraperitoneally at doses of 25, 50, 75 and 100 mg/kg for
the behavioral tests in order to determine its anxiolytic-like effect.
2.3. Animals
Male Swissmice (25–30 g), 2 months of age, were used throughout
this study. All the animals weremaintained at a controlled temperature
(26 ± 1 °C) on a 12 h light/dark cycle (lights on 06:00 am–18:00 pm)
with free access to water and food (Purina®). Different groups of mice
were used for each test.
All the experimentswere previously submitted for the approval of the
Ethics Committee onAnimal Experimentation of the Federal University of
Piauí (UFPI) (# 013/2011).
2.4. Experimental protocols
Initially, the animals were acclimatized in a site 24 h before the be-
havioral experiments. In the next step, themicewere randomly divided
into thirteen groups (10 mice per group), for the two protocol analysis.
In the ﬁrst protocol, there were a control group, treated with the
vehicle (negative control), four CA groups, with doses of 25, 50, 75
and 100 mg/kg and two groups of reference drugs (positive controls):
DZP (1 mg/kg) group and BUSP (5 mg/kg) group. After 30 min from
each administration, themicewere individually placed on each apparatus
and observed for 5 min (EPM; LDB; MBT of OFT) or 3 min for a Rota-rod
test. After each test, the equipment was washed with soap and water,
cleaned with ethanol 70% and dried for the subsequent mouse test. For
all the experiments, each mouse was tested only once. This protocol
was designed to test the anxiolytic-like potential and the inﬂuence on
the psychomotor activity of CA on the mice.
Once the CA anxiolytic-like potential was observed in the ﬁrst proto-
col, the second protocol was performed. One group of mice was treated
with FLU 25 mg/kg and another group with WAY 10 mg/kg. A third
group was formed with the administration of FLU 25 mg/kg, 15 min
before DZP 1 mg/kg administration, and a fourth group received FLU
25 mg/kg, 15 min before CA 100 mg/kg. This was the CA dose with the
best anxiolytic-like potential. The prior administration of FLU and then
DZP was aimed at conﬁrming that the FLU antagonized the GABAergic
effect of DZP (Almeida et al., 2012; Silva et al., 2011a). Furthermore, the
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like effect is related to GABAergic action.
Still in the second protocol, there was one group pretreated with
WAY 10 mg/kg 15 min before BUSP 5 mg/kg administration and one
group in which WAY 10 mg/kg was administered 15 min before CA
100 mg/kg. The previous administration of WAY aimed to conﬁrm the
inhibition of the anxiolytic effect of BUSP, as well as to test whether
CA anxiolytic-like activity is related to the serotonergic system.
All the groups were treated intraperitoneally 30 min before the test.
In the groups in which the antagonist (FLU or WAY) was ﬁrst applied,
the experiments were performed 30 min after administration of the
second drug (DZP, BUSP or CA 100).
2.4.1. Elevated plus-maze test
This test has been widely validated to measure anxiety in rodents
(Almeida et al., 2012; Karadeli et al., 2013). It consists of two open
arms (30 × 5 cm) and two enclosed arms (30 × 5 × 25 cm), with the
open arms perpendicular to the enclosed arms. The open and closed
arms converge to a central platform (5 × 5 cm). For both protocols,
each mouse was placed individually on the central platform, facing
directly a closed arm and the time spent in the open arms (TSOA) and
the number of open arms entries (NOAE) was recorded during the
total time of 5 min. After each test, the equipment was washed with
soap and water, cleaned with ethanol 70% and dried. Then, the subse-
quent mouse was tested.
2.4.2. Light–dark box test
This model has also been widely applied for testing anxiolytic-like
properties of drugs, including derivatives of natural products. The appa-
ratus is made with acrylic and is divided into two compartments
(boxes), one light and other dark, which communicate through a
small entry (Almeida et al., 2012; Crawley, 1981). The dark box (black
acrylic, 27 × 18 × 29 cm) is poorly lit. The light box (transparent acrylic,
27 × 18 × 29 cm) is illuminated by a light source of 60 W (400 lx). The
communication between the two environments is made by an entrance
of 5 × × 5 cm. The animals were initially placed individually in the dark
compartment, with the face directed at the communication between the
two environments and, then, observed for 5 min. After each test, the
equipment was washed with soap and water, cleaned with ethanol
70% and dried. Then, the subsequent mouse was tested. The parameters
used were the time spent in the light box (TSLB), expressed in seconds,
and the number of entries to the light box (NELB).
2.4.3. Marble-burying test
It has already been shown in literature that this is an effectivemethod
for testing the anxiolytic-like properties of a particular substance (Nicolas
et al., 2006). This procedure has beenwell described in rats by Poling et al.
(1981) and in mice (Badgujar and Surana, 2010). Rodents exhibit a
burying behavior in the presence of aversive stimuli as a source of
shock, harmful food or inanimate objects. The administration of a sub-
stance likely to have anxiolytic effects in rodents tend to reduce the
number of marbles buried (NMB) in this test. Therefore, in order to fur-
ther expand the evaluation of the CA anxiolytic-like properties, this
model was also added.
After treatment, the animals were placed, one at a time in the appa-
ratus, which consisted of an acrylic chamber with the distribution of 25
glassmarbles and the ﬂoor linedwith sawdust. The NMB in the sawdust
was reported. A marble was considered as hidden when it was at least
two-thirds covered by sawdust. Then, the sawdust and marbles were
washed with soap and water, cleaned with ethanol 70% and dried with
paper towels. Then, the subsequent mouse was tested.
2.4.4. Open-ﬁeld test
The open-ﬁeld arena was made of acrylic (transparent walls and
black ﬂoor, 30 × 30 × 15 cm) divided into nine squares of equal areas
(Archer, 1973). The mice were divided into six groups (n = 10animals). The different groups were treated with the vehicle (0.05%
Tween 80 dissolved in distilled water, ip) DZP (1 mg/kg ip) and CA
(25; 50; 75 and 100 mg/kg ip). After 30 min of each application, each
mouse was placed individually into the apparatus and the number of
squares crossed (NSC), with four legs on each square – spontaneous
locomotor activity –was measured during 5 min. After each individual
test session, the equipment was washed with soap and water, cleaned
with ethanol 70% and dried. Then, the subsequent mouse was tested.
2.4.5. Rota-rod test
The equipment of Rota-rodwas used to evaluatemotor coordination
produced by drugs in animals (Carlini and Burgos, 1979; Vale et al.,
2002). The mice were trained before the experiment to acquire the ca-
pacity to remain for 180 s on a diameter rod, rotating at 17 rpm. Two
or three trials were sufﬁcient for the animals to learn this task. DZP
(1 mg/kg, ip), CA (25; 50; 75 and 100 mg/kg, ip) and the vehicle
(10 ml/kg, ip) were administered 30 min before the test in each of
the experimental groups (n = 10). Then, the animals were placed in
the four paws on the rotating bar, which is 2.5 cm in diameter is 25 cm
high from the ﬂoor. The animals were observed for a period of three mi-
nutes. The ability of the mice to remain on the rota-rod for 180 s – the
time spent on the rotating bar (TSRB) – and the number of falls (NF)
(up to three drops) were recorded. After each test, the equipment was
washed with soap and water, cleaned with ethanol 70% and dried.
Then, the subsequent mouse was tested.
2.5. Statistical analyzes
All the results were presented as mean ± standard error of the
mean (SEM). The data were evaluated by analysis of variance
(ANOVA) followed by Student's t-test and Neuman–Keuls post hoc
test. The data were analyzed using GraphPad Prism 5.0 (San Diego,
CA, USA). The experimental groups were compared to the vehicle
group and the two positive controls — DZP and BUSP. Differences
were considered statistically signiﬁcant when p b0.05.
3. Results
3.1. Elevated plus-maze test
In the ﬁrst protocol, it was observed that TSOAwas increased by 44,
83, 90 and 189% in the groups treatedwith CA 25, 50, 75 and 100 mg/kg,
respectively, when compared to the vehicle [F (13,102.7) = 1.322,
p b 0.0001].When compared toDZP, CA100 effectwas 57% better. Com-
pared to BUSP, there was a 25% better effect to CA100 [F (13,102.7) =
1.322, p b 0.0001] (Fig. 2A). NOAE in the CA100 group was increased
by 208% when compared to the vehicle and 50% and 62.5% when
compared to DZP and BUSP, respectively [F (13,37.30) = 1.811,
p b 0.0001] (Fig. 2B). When CA100 was compared to CA75 for TSOA
and NOAE, CA100 had a better effect by 52% [F (13,102.7) = 1.322,
p b 0.0001] and 113% [F (13,37.30) = 1.811, p b 0.0001], respectively
(Fig. 2). In addition, when compared to the vehicle, the increase in
TSOA caused by CA100 was accompanied by an increase in NOAE.
In the second protocol, the inhibition of the anxiolytic effect of DZP
was observed when FLU + DZP reduced the TSOA by 87% when com-
pared to DZP (Fig. 2A) and the NOAE by 77% when compared to DZP
[F (13,102.7) = 1.322, p b 0.0001] (Fig. 2B). FLU + CA100 reduced
TSOA and NOAE by 150% [F (13,102.7) = 1.322, p b 0.0001] and 53%
[F (13,37.30) = 1.811, p b 0.0001] when compared to CA100, respec-
tively. FLU + CA100 reduced both TSOA and NOAE by values which
were not signiﬁcant when compared to the vehicle [F (13,102.7) =
1.322, p N 0.05] and [F (13,37.30) = 1.811, p N 0.05], respectively,
suggesting a reversal effect on these parameters. When WAY + BUSP
were compared to BUSP, there was inhibition of the anxiolytic effect of
BUSP by 120% on TSOA [F (13,102.7) = 1.322, p b 0.0001] (Fig. 2A)
and 76% on NOAE [F (13,37.30) = 1.811, p b 0.0001] (Fig. 2B). However,
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on the TSOA [F (13,102.7) = 1.322, p N 0.05] (Fig. 2A).3.2. Light–dark box test
In the ﬁrst protocol, CA 25, 50, 75 and 100 mg/kg increased
TSLB by 88%, 118%, 132% and 182% when compared to the vehicle
[F (13,38.66) = 1.156, p b 0.0001] (Fig. 3A). When CA100 was
compared to BUSP and DZP, there was an increase respectively
by 22% [F (13,38.66) = 1.156, p b 0.001] and 23% for CA100
[F (13,38.66) = 1.156, p b 0.0001] on the TSLB (Fig. 3A). Regarding
NELB in comparison to the vehicle, CA25, 50, 75 and 100 increased it
by 70%, 80%, 100% and 157%, respectively [F (13,14.45) = 1.873,
p b 0.0001]. Additionally, CA 100 mg/kg increased the NELB by 51%
when compared with DZP [F (13,14.45) = 1.873, p b 0.0001] and
63% when compared with BUSP [F (13,14.45) = 1.873, p b 0.0001]
on the NELB (Fig. 3B). CA100 had a still better effect than CA75 in
both TSLB and NELB respectively by 22% [F (13,38.66) = 1.156,
p b 0.05] and 29% [F (13,14.45) = 1.873, p b 0.001] (Fig. 3A and B).
In the second protocol, FLU + DZP reduced TSLB by 119%
[F (13,38.66) = 1.156, p b 0.0001] (Fig. 3A) and NELB by 62%
[F (13,14.45) = 1.873, p b 0.0001] when compared to DZP (Fig. 3B).
Furthermore, when comparing the groups WAY + BUSP and BUSP
the ﬁrst reduced TSLB by 37% [F (13,38.66) = 1.156, p b 0.0001,
p b 0.0001] (Fig. 3A).
When FLU + CA100was compared to CA100, therewas a reduction
by 110% in TSLB [F (13,38.66) = 1.156, p b 0.001] (Fig. 3A) and 157% in
NELB [F (13,14.45) = 1.873, p b 0.001] (Fig. 3B). FLU + CA100
reduced both TSLB and NELB by values which were not signiﬁcant
when compared to the vehicle, suggesting a reversal effect on theseFig. 2. Time spent in the open arms (TSOA) and number of open arms entries (NOAE) in the e
when compared to the control group (vehicle), bp b 0.0001 when compared to DZP, cp b 0.000
by Student's t-test and Neuman–Keuls post hoc test). CA: carvacryl acetate; BUSP: buspirone;parameters. However, when WAY + CA100 was compared to CA100
on the TSLB, there was no statistical signiﬁcance [F (13,38.66) =
1.156, p N 0.05].3.3. Marble-burying test
When compared to the vehicle, NMB of themice treatedwith CA 25,
50, 75 and 100 was reduced respectively by 47%, 52%, 55% and 74%
[F (13,91.45) = 4.167, p b 0.0001], which suggests the anxiolytic-like
effect of CA. In addition, the CA100 reducedNMB by 35%when compared
to DZP [F (13,91.45) = 4.167, p b 0.05] and by 49% when compared
to BUSP [F (13,91.45) = 4.167, p b 0.0001] in the ﬁrst protocol. CA100
had also a superior anxiolytic-like effect to CA75 which was 43% greater
[F (13,91.45) = 4.167, p b 0.001] (Fig. 4).
In the second protocol, FLU + DZP decreased by 163% the effect of
DZP on NMB [F (13,91.45) = 4.167, p b 0.0001] and WAY + BUSP
reduced by 125% the effect of BUSP on NMB [F (13,91.45) = 4.167,
p b 0.0001]. FLU + CA100 reduced by 174% the effect of CA100 on
NMB [F (13,91.45) = 4.167, p b 0.0001], and FLU + CA100 was
not signiﬁcant when compared to the vehicle in this parameter
[F (13,91.45) = 4.167, p N 0.05], causing a reversal of the CA100
effect. However, no signiﬁcant difference was observed between
WAY + CA100 and CA100 [F (13,91.45) = 4.167, p N 0.05] (Fig. 4).3.4. Open-ﬁeld test
The group treated with DZP 1 mg/kg ip had NSC reduced by 53.9%
when compared with the vehicle [F (6,137.4) = 6.271, p b 0.0001]
(Fig. 5). However, the mice treated with CA 25; 50; 75 or 100 mg/kglevated plus-maze (EPM) test. The values were represented as mean ± SEM. ap b 0.0001
1 when compared to BUSP and dp b 0.0001 when compared to CA100 (ANOVA followed
DZP: diazepam; FLU: ﬂumazenil; WAY: WAY 100635.
Fig. 3. Time spent in the light box (TSLB) and number of entries to the light box (NELB) in Ligh–dark box (LDB) test. The values were represented as mean ± SEM. ap b 0.001
when compared to the control group (vehicle), bp b 0.001 when compared to DZP, cp b 0.0001 when compared to BUSP and dp b 0.001 when compared to CA100 (ANOVA followed
by Student's t-test and Neuman–Keuls post hoc test). CA: carvacryl acetate; BUSP: buspirone; DZP: diazepam; FLU: ﬂumazenil; WAY: WAY 100635.
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[F (6,137.4) = 6.271, p N 0.05].
3.5. Rota-rod test
The animals treadwith DZP 1 mg/kg ip had NF increased by 121.43%
when compared to the vehicle [F (6,11.43) = 1.214, p b 0.05], whileFig. 4. Number of marbles buried (NMB) in the marble-burying test (MBT). The values were r
bp b 0.05 when compared to DZP, cp b 0.0001 when compared to BUSP and dp b 0.0001 whe
test). CA: carvacryl acetate; BUSP: buspirone; DZP: diazepam; FLU: ﬂumazenil; WAY: WAY 10the CA groups had not statistical difference when compared to the
vehicle [F (6,11.43) = 1.214, p N 0.05] (Fig. 6A).
Considering the TSRB, the mice tread with DZP 1 mg/kg ip had
this parameter reduced by 16.93% when compared to the vehicle
[F (6,76.37) = 1.605, p b 0.05], while CA groups had no statistical
difference when compared to the vehicle [F (6,76.37) = 1.605,
p N 0.05] (Fig. 6B).epresented as mean ± SEM. ap b 0.0001 when compared to the control group (vehicle),
n compared to CA100 (ANOVA followed by Student's t-test and Neuman–Keuls post hoc
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Fig. 6.Number of falls (NF) (A) and time spent on the rotating bar (TSRB) (B) in the Rota-rod
test. The values were represented asmean ± SEM. ap b 0.05 when compared to the control
group (vehicle) (ANOVA followed by Student's t-test and Neuman–Keuls post hoc test). CA:
carvacryl acetate; DZP: diazepam.
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In the present studywe explored the anxiolytic-like effects of different
doses of CA using three behavioralmodels (EPM, LDB andMBT) and com-
paring them with the effects of DZP and BUSP.
In the EPM, it is known that anxiolytic drugs such as DZP lead animals
to increase theNOAE and the TSOA,whilst anxiogenic drugs induce an in-
crease in the number of entries and in the time spent in the closed arms
(Walf and Frye, 2007). Likewise, it is known that in the LDB, anxiolytic
drugs tend to increase the NELB and the TSLB (Crawley, 1981). And ﬁnal-
ly, in theMBT, anxiolytic drugs tend to reduce the NMB, which also char-
acterizes an anxiolytic-like activity (Almeida et al., 2012; Badgujar and
Surana, 2010). As it is known, rodents bury a variety of conditioned and
unconditioned aversive stimuli. Such burying has been considered as a
species-typical defensive reaction. The rodents, when feeling threatened,
tend to bury food and innocuous solids, like glass marbles (Poling et al.,
1981). Therefore, a compoundwhich reduces theNMBmayhave apoten-
tial to be studied as an anxiolytic drug.
In the ﬁrst experimental protocol, it was found that CA had
anxiolytic-like potential in EPM, LDB and MBT at all doses, and the
higher the dose, the greater the effect.
In EPM, the increase on TSOA caused by CA100was accompanied by
an increase on NOAE, suggesting no psychomotor retardation at that
dose of CA (Section 3.1).
In LDB, all four CA doses increased both TSLB and NELB when com-
pared to the vehicle, corroborating that the effect of CA in this test prob-
ably did not cause psychomotor retardation (Section 3.2).
Reinforcing that CA at the doses used do not interfere in the psycho-
motor activity, in OFT no differencewas observed onNSC, suggesting no
locomotor retardation effect of CA, differently from what was observed
with DZP (Section 3.4). The Rota-rod test demonstrated, additionally, no
motor coordination impairment of CA 25; 50; 75 and 100 mg/kg ip,
which is also the contrary to what was observed with DZP (Section 3.5).
This means that the common side effects on the psychomotor activity
during the treatment of anxiety disorders with benzodiazepine probably
may not exist with the CA treatment (Silva et al., 2011b).
Finishing the analysis of the ﬁrst protocol, it is important to consider
that we previously tested the doses of CA at 1 mg/kg and 5 mg/kg and
they did not demonstrate anxiolytic-like activity in any of the three
models of anxiety.
In the second protocol, considering EPM results, FLU + CA100
reduced TSOA when compared to CA100 (Section 3.1), and, in LDB,
FLU + CA100 reversed the anxiolytic-like effect of CA100 on both
TSLB and on NELB (Section 3.2). In MBT, FLU + CA100 also reversed
the effect of CA100, but not signiﬁcantly when compared to the vehicle
(Section 3.3). These results suggest that the anxiolytic-like potential of
CA may occur, at least in part, due to a probable agonistic action on
the GABAergic system.Fig. 5.Number of squares crossed (NSC) in the open-ﬁeld test (OFT). The valueswere rep-
resented as mean ± SEM. ap b 0.0001 when compared to the control group (vehicle)
(ANOVA followed by Student's t-test and Neuman–Keuls post hoc test). CA: carvacryl
acetate; DZP: diazepam.Likewise, as it is already known that BUSP has its anxiolytic property
due to an agonist action on 5-HT1A receptors (Ferreira et al., 2012), pre-
treatment withWAY reversed the anxiolytic effect of BUSP in EPM, LDB
and MBT. So, to be tested if the CA anxiolytic-like potential could be in-
volved on the serotonergic system, a group of mice was pretreated with
WAY, followed by administration of CA100.
In EPM, the WAY did not reverse the anxiolytic-like effect of CA100
on the TSOA (Section 3.1). Similarly, LDB results have suggested that
the anxiolytic-like activity of CA is not related to the serotonergic sys-
tem, as WAY + CA100 showed no signiﬁcant difference from CA100
on TSLB (Section 3.2). This idea was corroborated in MBT, when the
WAY + CA100 group caused no signiﬁcant change in NMB when com-
pared to CA100 (Section 3.3).
It is important to consider that this studywas conducted onmice be-
cause low doses of CA were necessary in the experiments and the mice
are considered to have good reproducibility in experimental pharmaco-
logical models. However, it should be emphasized that tests with other
species of rodents will be conducted by our group to compare the re-
sults and verify the reproducibility of the same pharmacological models
used in this study.
Since CA is an acetylated form of a monoterpene (carvacrol), we
compared the CA anxiolytic-like effect with anxiolytic-like effects of
monoterpenes and derivatives of monoterpenes obtained from other
studies. A study in which epoxy-limonene (EL) was administrated at
25, 50 and 75 mg/kg in Swiss mice subsequently submitted to EPM
demonstrated that the TSOA was increased by 47, 48.2 and 74.4%, re-
spectively, when compared to the vehicle (p b 0.01) (ANOVA followed
by Student's t-test and Neuman–Keuls post hoc test) (Almeida et al.,
2012). However, CA showed better increases in TSOA for the doses of
50 and 75 mg/kg when compared to the vehicle (Section 3.1).
48 L.F. Pires et al. / Pharmacology, Biochemistry and Behavior 112 (2013) 42–48In another study, it was tested in EPM the probable anxiolytic-like
activity of citral, myrcene and limonene, constituents of the essential
oil of Lippia alba (Mill.) (Melo et al., 2010). No effects on TSOA after
administration of the three monoterpenes in doses of 5, 10, 25 and
50 mg/kg ip in mice were observed. Nevertheless, there was a small
yet signiﬁcant effect of limonene at 5 mg/kg ip, which instead of having
increased NOAE, decreased it by 30% when compared to control
(p b 0.05). Therefore, despite being derived from a monoterpene, CA
followed a different trend from citral, limonene and myrcene, but a simi-
lar tendency to carvacrol, from which CA is derived, once an anxiolytic-
like property of carvacrol has already been recognized in a previous
study. The CA resulted from an insertion of an acetate molecule on the
chemical structure of carvacrol, which may facilitate the penetration
through the blood–brain barrier since it increases the liposolubility.
Thus, probably lower doses of CA may be necessary to exert the possible
anxiolytic-like effect when hypothetically compared with carvacrol, in-
creasing, therefore, a safe use of this drug in a possible clinical study in
the future (Melo et al., 2010).
Thus, the results of this study demonstrate that CA presents a poten-
tial anxiolytic-like effect in three widely used experimental models of
anxiety, without evidence of causing psychomotor retardation of the
mice under the doses used. The evidences indicate that it probably
acts on the GABAergic system, but not on the 5-HT1A receptors.
5. Conclusion
By providing unpublished data about CA anxiolytic-like potential, as
well as its probable mechanism of action, which seems not to interfere
in the psychomotor activity in the doses used, this paper suggests that
CA features a large potential to be studied as an alternative drug for
the treatment of anxiety disorders.
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